report by BlackRock
Results for ""
Market Outlooks
3Q22 Capital Markets Outlook - Walking a Tightrope
This piece is approved to use with clients.
Entering 3Q, a higher headline inflation print pushed an already aggressive US Fed into overdrive. Markets have responded in kind- fears of a recession have grown, adding pressure to equity valuations and pushing yields higher. Brink identifies some of those select equity and fixed income opportunities. Watch as AB's Rick Brink recap this quarter's outlook for the global capital markets.
Investing Ideas
A Guide to Investing in a Time of COVID-19…and Beyond
This piece is approved to use with clients.
It looks like investing is about to get a lot harder, with thinner return streams and potential pitfalls from ill-timed market sell-offs dominating the post-COVID-19 landscape.
Portfolio Construction Insights
Technology Enables Municipal Investing at the Speed of Alpha
This piece is approved to use with clients.
Today's complex, fragmented and fast-moving muni market is rapidly outpacing the capability and capacity of traditional portfolio-construction methods.
Market Outlooks
The Hunt for Quality: Searching for Durable Stocks in Uncertain Times
This piece is approved to use with clients.
High-quality companies are always in style. In good times and bad, features that define resilient businesses and stocks underpin consistent and solid equity return potential. But to consistently find companies that meet the highest quality standards requires research, judgment and investing skill.
Macroeconomic & Geopolitical
Anatomy of a Recession Long View: 2022--The Year of Transition
This piece is approved to use with clients.
ClearBridge Investments believe that inflationary pressure will begin to moderate in a few quarters and transition toward the Fed’s 2% target.
Policy and Regulatory Commentary
With More Stimulus on the Horizon, Fed Expects a Strong Recovery in 2021
This piece is approved to use with clients.
The Federal Reserve in March raised its forecasts for GDP growth, inflation and employment, based on the $1.9 trillion in new stimulus signed into law and an accelerated vaccine rollout.